Evidence map›Paper›PMID 33482870›Full record

ArticleOrphanet journal of rare diseases2021

Myopia-26, the female-limited form of early-onset high myopia, occurring in a European family.

Noémi Széll, Tamás Fehér, Zoltán Maróti, Tibor Kalmár, Dóra Latinovics, István Nagy, Zsuzsanna Z Orosz, Márta Janáky, Andrea Facskó, Zoltán Sohajda

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Zoological research · 2026
    Article
  3. Article
  4. Article
  5. IMI-Myopia Genetics Report.Investigative ophthalmology & visual science · 2025
    Review
  6. Advances in the study of ARR3 in myopia.Frontiers in cell and developmental biology · 2025
    Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Genetic and clinical landscape ofThe British journal of ophthalmology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Identification of a Novel Frameshift Variant ofJournal of clinical medicine · 2023
    Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Noémi SzéllKenézy Gyula University Hospital, Debrecen Medical University, Debrecen, Hungary.
Tamás FehérInstitute of Biochemistry, Biological Research Centre, Szeged, Hungary. feher.tamas@brc.hu.ORCID 0000-0001-9318-3640
Zoltán MarótiGenetic Diagnostic Laboratory, University of Szeged, Szeged, Hungary.
Tibor KalmárGenetic Diagnostic Laboratory, University of Szeged, Szeged, Hungary.
Dóra LatinovicsSeqomics Biotechnology Ltd, Mórahalom, Hungary.
István NagyInstitute of Biochemistry, Biological Research Centre, Szeged, Hungary.
Zsuzsanna Z OroszDepartment of Ophthalmology, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Márta JanákyDepartment of Ophthalmology, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Andrea FacskóDepartment of Ophthalmology, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Zoltán SohajdaKenézy Gyula University Hospital, Debrecen Medical University, Debrecen, Hungary. zoltansohajda@hotmail.com.
University of Szeged · HUHUN-REN Szegedi Biológiai Kutatóközpont · HUUniversity of Debrecen · HUSeqOmics Biotechnology (Hungary) · HU

Funding

Gazdaságfejlesztési és Innovációs Operatív Program (HU) GINOP-2.3.2-15-2016-00001Nemzeti Kutatási Fejlesztési és Innovációs Hivatal K119298
6 · The paper itself

Abstract

backgroundFemale-limited early-onset high myopia, also called Myopia-26 is a rare monogenic disorder characterized by severe short sightedness starting in early childhood and progressing to blindness potentially by the middle ages. Despite the X-linked locus of the mutated ARR3 gene, the disease paradoxically affects females only, with males being asymptomatic carriers. Previously, this disease has only been observed in Asian families and has not gone through detailed investigation concerning collateral symptoms or pathogenesis.

resultsWe found a large Hungarian family displaying female-limited early-onset high myopia. Whole exome sequencing of two individuals identified a novel nonsense mutation (c.214C>T, p.Arg72*) in the ARR3 gene. We carried out basic ophthalmological testing for 18 family members, as well as detailed ophthalmological examination (intraocular pressure, axial length, fundus appearance, optical coherence tomography, visual field- testing) as well as colour vision- and electrophysiology tests (standard and multifocal electroretinography, pattern electroretinography and visual evoked potentials) for eight individuals. Ophthalmological examinations did not reveal any signs of cone dystrophy as opposed to animal models. Electrophysiology and colour vision tests similarly did not evidence a general cone system alteration, rather a central macular dysfunction affecting both the inner and outer (postreceptoral and receptoral) retinal structures in all patients with ARR3 mutation.

conclusionsThis is the first description of a Caucasian family displaying Myopia-26. We present two hypotheses that could potentially explain the pathomechanism of this disease.

Indexed as

Evoked Potentials, VisualMyopiaChild, PreschoolDNA Mutational AnalysisElectroretinographyFemaleHumansMaleMiddle AgedMutationPedigreeTomography, Optical CoherenceARR3Early onset high myopiaG-protein coupled receptorIntrinsically photosensitive retinal ganglion cellMendelian inheritanceMonogenic disorderX-arrestinX-linked female-limited high myopia

Identifiers

PMID33482870
PMCPMC7825233
OpenAlexW3122408108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.